國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Hypofractionated and stereotactic ra...

Chen, Ronald.

Hypofractionated and stereotactic radiation therapya practical guide /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Hypofractionated and stereotactic radiation therapyedited by Orit Kaidar-Person, Ronald Chen.
其他題名:	a practical guide /
其他作者:	Kaidar-Person, Orit.
出版者:	Cham :Springer International Publishing :2018.
面頁冊數:	xxvii, 406 p. :digital ;24 cm.
Contained By:	Springer eBooks
標題:	Radiotherapy.
電子資源:	http://dx.doi.org/10.1007/978-3-319-92802-9
ISBN:	9783319928029$q(electronic bk.)

Hypofractionated and stereotactic radiation therapya practical guide /
Hypofractionated and stereotactic radiation therapya practical guide /[electronic resource] :edited by Orit Kaidar-Person, Ronald Chen. - Cham :Springer International Publishing :2018. - xxvii, 406 p. :digital ;24 cm.

Biological Rationale for Hypofractionated Radiation Therapy -- Modern Physics and Technological Developments for Delivery of Hypofractionated Radiation Therapy -- Prostate Cancer -- Breast Cancer -- Lung Cancer -- Skin Cancer -- Central Nervous System Tumors -- Gastrointestinal Cancer -- Gynecologic Cancer -- Pediatric Cancer -- Palliation.

This handbook summarizes the data and techniques for hypofractionation and stereotactic radiation in a clinically-accessible way. Hypofractionated radiation therapy, which consists of larger-dose radiation treatments that are given over a shorter time period compared to conventional radiation fraction sizes, is used to treat a variety of cancers, including prostate, breast, lung, and colorectal. Conventional radiation therapy and hypofractionated radiation therapy have different effectiveness rates for cancer treatment and have different impacts on normal tissues in terms of causing toxicity. There is a significant and growing body of literature on the use of different dosing regimens to treat a variety of cancers and radiation oncologists need to keep up with the various dosing schedules, the effect of each regimen on cancer control in different cancers, and how the different schedules affect each organ in terms of toxicity. The book thus provides concise information ranging from commonly-used dose-fractionation schemes for hypofractionated and stereotactic body radiotherapy to simulation and treatment specifications to published safety and efficacy data. Chapters additionally examine the biological rationales for the efficacy of hypofractionated radiation; present clinical studies that demonstrate the efficacy and safety of hypofractionated radiation treatment in a variety of cancers; and describe the advances in technology that have allowed hypofractionated radiation to be safely given. This is an ideal guide for radiation oncology clinicians and trainees.

ISBN: 9783319928029$q(electronic bk.)

Standard No.: 10.1007/978-3-319-92802-9doiSubjects--Topical Terms:

274202
Radiotherapy.

LC Class. No.: RM847 / .H976 2018

Dewey Class. No.: 615.842

Hypofractionated and stereotactic radiation therapya practical guide /
LDR:02893nmm a2200313 a 4500 001 543177
003 DE-He213
005 20190131135250.0
006 m d
007 cr nn 008maaau
008 190411s2018 gw s 0 eng d
020 $a 9783319928029$q(electronic bk.)
020 $a 9783319928005$q(paper)
024 7 $a 10.1007/978-3-319-92802-9 $2 doi
035 $a 978-3-319-92802-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RM847 $b .H976 2018
072 7 $a MJCL1 $2 bicssc
072 7 $a MED080000 $2 bisacsh
082 0 4 $a 615.842 $2 23
090 $a RM847 $b .H998 2018
245 0 0 $a Hypofractionated and stereotactic radiation therapy $h [electronic resource] : $b a practical guide / $c edited by Orit Kaidar-Person, Ronald Chen.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a xxvii, 406 p. : $b digital ; $c 24 cm.
505 0 $a Biological Rationale for Hypofractionated Radiation Therapy -- Modern Physics and Technological Developments for Delivery of Hypofractionated Radiation Therapy -- Prostate Cancer -- Breast Cancer -- Lung Cancer -- Skin Cancer -- Central Nervous System Tumors -- Gastrointestinal Cancer -- Gynecologic Cancer -- Pediatric Cancer -- Palliation.
520 $a This handbook summarizes the data and techniques for hypofractionation and stereotactic radiation in a clinically-accessible way. Hypofractionated radiation therapy, which consists of larger-dose radiation treatments that are given over a shorter time period compared to conventional radiation fraction sizes, is used to treat a variety of cancers, including prostate, breast, lung, and colorectal. Conventional radiation therapy and hypofractionated radiation therapy have different effectiveness rates for cancer treatment and have different impacts on normal tissues in terms of causing toxicity. There is a significant and growing body of literature on the use of different dosing regimens to treat a variety of cancers and radiation oncologists need to keep up with the various dosing schedules, the effect of each regimen on cancer control in different cancers, and how the different schedules affect each organ in terms of toxicity. The book thus provides concise information ranging from commonly-used dose-fractionation schemes for hypofractionated and stereotactic body radiotherapy to simulation and treatment specifications to published safety and efficacy data. Chapters additionally examine the biological rationales for the efficacy of hypofractionated radiation; present clinical studies that demonstrate the efficacy and safety of hypofractionated radiation treatment in a variety of cancers; and describe the advances in technology that have allowed hypofractionated radiation to be safely given. This is an ideal guide for radiation oncology clinicians and trainees.
650 0 $a Radiotherapy. $3 274202
650 0 $a Stereotaxic techniques. $3 459573
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Oncology. $3 195181
700 1 $a Kaidar-Person, Orit. $3 821337
700 1 $a Chen, Ronald. $3 821338
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-92802-9
950 $a Medicine (Springer-11650)